Tirzepatide - High Purity Research Peptide

Tirzepatide – High-Purity Research Peptide

Tirzepatide is a groundbreaking synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. With its 39-amino acid sequence, it mimics the effects of both natural incretin hormones, making it a valuable tool for researchers investigating metabolic disorders, insulin sensitivity, and energy balance.

In laboratory and preclinical studies, Tirzepatide has been examined for its potential to:

•  Enhance insulin secretion in a glucose-dependent manner

•  Suppress glucagon release

•  Slow gastric emptying

•  Reduce appetite and food intake via central nervous system pathways

•  Promote significant improvements in glycaemic control and body weight regulation

Its dual-receptor mechanism distinguishes it from single GLP-1 agonists, offering researchers a unique opportunity to explore synergistic effects on metabolic health, cardiovascular parameters, and long-term energy homeostasis in experimental models.

At GB-Peptides, we supply premium-grade Tirzepatide manufactured to the highest standards:

•  ≥99% purity (verified by HPLC and MS)

•  Third-party laboratory tested with full Certificates of Analysis available upon request

•  Lyophilized powder for optimal stability and long shelf life

•  Discreet and fast shipping across the UK

•  Reconstitute with BAC Water

Important Notice:

This product is sold strictly for laboratory and scientific research purposes only. It is not intended for human consumption, therapeutic use, diagnosis, or treatment of any medical condition. Researchers must ensure full compliance with all applicable UK laws and regulations.

Whether your research focuses on incretin biology, obesity models, type 2 diabetes mechanisms, or novel metabolic therapies, Tirzepatide from GB-Peptides delivers the purity and reliability your studies require.